Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5075403
Max Phase: Preclinical
Molecular Formula: C41H40N8O7
Molecular Weight: 756.82
Molecule Type: Unknown
Associated Items:
ID: ALA5075403
Max Phase: Preclinical
Molecular Formula: C41H40N8O7
Molecular Weight: 756.82
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1C(=O)CCC(N2C(=O)c3cccc(N4CCN(C(=O)C5CCN(c6ccc(NC(=O)c7cnc(Oc8ccccc8)nc7)cc6)CC5)CC4)c3C2=O)C1=O
Standard InChI: InChI=1S/C41H40N8O7/c1-45-34(50)15-14-33(39(45)54)49-38(53)31-8-5-9-32(35(31)40(49)55)47-20-22-48(23-21-47)37(52)26-16-18-46(19-17-26)29-12-10-28(11-13-29)44-36(51)27-24-42-41(43-25-27)56-30-6-3-2-4-7-30/h2-13,24-26,33H,14-23H2,1H3,(H,44,51)
Standard InChI Key: UUILKUWMNHXPIN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 756.82 | Molecular Weight (Monoisotopic): 756.3020 | AlogP: 3.83 | #Rotatable Bonds: 8 |
Polar Surface Area: 165.66 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.90 | CX Basic pKa: 5.10 | CX LogP: 3.15 | CX LogD: 3.14 |
Aromatic Rings: 4 | Heavy Atoms: 56 | QED Weighted: 0.26 | Np Likeness Score: -1.30 |
1. Yokoo H, Shibata N, Endo A, Ito T, Yanase Y, Murakami Y, Fujii K, Hamamura K, Saeki Y, Naito M, Aritake K, Demizu Y.. (2021) Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design., 64 (21.0): [PMID:34652145] [10.1021/acs.jmedchem.1c01206] |
Source(1):